Hemodialysis and peritoneal dialysis are life-sustaining renal replacement therapies. Hemodialysis employs a machine to filter blood, eliminating waste and excess fluids, while peritoneal dialysis uses the peritoneum's membrane within the abdomen for this process. Both methods are vital for patients with kidney failure. Hemodialysis offers efficient toxin removal and is usually clinic-based. Peritoneal dialysis offers home-based, continuous treatment, providing more flexibility. These therapies significantly enhance the quality of life for individuals suffering from end-stage renal disease (ESRD) or severe kidney dysfunction.
According to Data Bridge Market Research, the Global Hemodialysis and Peritoneal Dialysis Market is expected to grow with a CAGR of 6.55% in the forecast period of 2022 to 2029.
“Rising number of end-stage renal disease (ESRD) patients boosts the market’s growth”
The hemodialysis and peritoneal dialysis market is experiencing growth due to the rising number of end-stage renal disease (ESRD) patients. ESRD is a severe kidney condition necessitating regular dialysis to remove waste and excess fluids from the bloodstream. As ESRD cases increase, so does the demand for dialysis treatments. This trend is driven by factors such as an aging population, a higher incidence of diabetes and hypertension, and improved access to healthcare. Consequently, the hemodialysis and peritoneal dialysis market is expanding to meet the growing demand for life-sustaining renal care.
What restraints the growth of the global hemodialysis and peritoneal dialysis market?
“Risks and complications associated with these treatments restraint the market’s growth”
The growth of the hemodialysis and peritoneal dialysis market is hindered by the significant risks and complications associated with these treatments. Dialysis can lead to adverse events such as infections, cardiovascular issues, and complications related to the vascular access needed for hemodialysis. Peritoneal dialysis carries risks of infection and catheter-related problems. These complications pose a challenge to patient safety and comfort, creating a reluctance among both patients and healthcare providers.
Segmentation: Global Hemodialysis and Peritoneal Dialysis Market
The global hemodialysis and peritoneal dialysis market are segmented on the basis of hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products, and services, peritoneal dialysis modality, disease indication, usage and end user.
- On the basis of hemodialysis products, the hemodialysis and peritoneal dialysis market is segmented into hemodialysis machines, center-use hemodialysis machines, home-use hemodialysis machines, and hemodialysis consumables and supplies.
- On the basis of dialyzers material type, the hemodialysis and peritoneal dialysis market is segmented into synthetic dialyzers and cellulose-based dialyzers.
- On the basis of flux type, the hemodialysis and peritoneal dialysis market is segmented into high-flux, dialyzers, low flux dialyzers, bloodlines sets and tubes, hemodialaysis concentrates/dialysates, alkaline concentrates, acidic concentrates, hemodialysis access products, AV fistula needles, arteriovenous grafts, central venous catheters and other hemodialysis consumables.
- On the basis of hemodialysis modality, the hemodialysis and peritoneal dialysis market is segmented into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).
- On the basis of hemodialysis water treatment systems, the hemodialysis and peritoneal dialysis market is segmented into central water disinfection systems and portable water disinfection systems.
- On the basis of peritoneal dialysis products and services, the hemodialysis and peritoneal dialysis market is segmented into peritoneal dialysis concentrates/dialysates, peritoneal dialysis machines, peritoneal dialysis catheters, peritoneal dialysis transfer sets, other products, and peritoneal dialysis services.
- On the basis of peritoneal dialysis modality, the hemodialysis and peritoneal dialysis market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and ambulatory peritoneal dialysis (APD).
- On the basis of disease indication, the hemodialysis and peritoneal dialysis market is segmented into acute kidney infections, ESRD, septic shock, multi-organ failure and others.
- On the basis of usage, the hemodialysis and peritoneal dialysis market is segmented into in-center dialysis, hospital dialysis, independent dialysis, home dialysis, peritoneal dialysis, and home hemodialysis (HHD).
- On the basis of end user, the hemodialysis and peritoneal dialysis market is segmented into hospitals, dialysis centers, and home care settings.
Regional Insights: North America dominates the Global Hemodialysis and Peritoneal Dialysis Market
North America dominates the hemodialysis and peritoneal dialysis market due to the proliferation of treatment centers and the introduction of innovative dialysis products. This expansion enhances accessibility to renal care and provides patients with a broader range of treatment options, fostering market growth and improving the quality of care for those with kidney diseases.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 owing to its substantial target population. A high prevalence of kidney diseases and an aging demographic contribute to a large patient pool in need of dialysis treatments. This demographic trend fuels market growth, as the demand for renal care continues to rise.
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/global-hemodialysis-peritoneal-dialysis-market
The Prominent Key Players Operating in the Global Haemodialysis and Peritoneal Dialysis Market Include:
- DaVita Inc. (U.S.)
- Baxter (U.S.)
- B. Braun Melsungen AG (Germany)
- Diaverum (Sweden)
- Nipro (Japan)
- Nxstage Medical, Inc. (U.S.)
- Nikkiso Co., Ltd. (Japan)
- Mar Cor Purification (U.S.)
- Asahi Kasei Medical Co., Ltd. (Japan)
- Rockwell Medical (U.S.)
- Medtronic (U.S.)
- Dialifegroup (U.S.)
- JMS Co. Ltd. (Japan)
- Atlantic Biomedical (U.S.)
- 3M (U.S.)
- Allmed Medical Care Holdings Limited (China)
- Isopure Corp. (U.S.)
- C. R. Bard, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global hemodialysis and peritoneal dialysis market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: Global Hemodialysis and Peritoneal Dialysis Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
